Since its foundation in 1929 by Henri Beaufour, Ipsen has offered a wide range of products in consumer healthcare, oncology, endocrinology and neurology available to patients. Locations abroad, acquisitions, partnerships, scientific collaborations and innovations: learn about the development of our group over the years.

April 1st: Ipsen opened its new peptide-driven R&D center in Cambridge (USA).
Read more
Last update 25/07/2016